methodological error 23 scaffoldbased splitting (Bemis Inc)
86
Structured Review
Bemis Inc
methodological error 23 scaffoldbased splitting
Methodological Error 23 Scaffoldbased Splitting, supplied by Bemis Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a+split/23+error+methodological+scaffoldbased+splitting/pm42300227-17-29-33
Average 86 stars, based on 1 article reviews
Methodological Error 23 Scaffoldbased Splitting, supplied by Bemis Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a+split/23+error+methodological+scaffoldbased+splitting/pm42300227-17-29-33
Average 86 stars, based on 1 article reviews
methodological error 23 scaffoldbased splitting - by Bioz Stars,
2026-11
86/100 stars
Images
Related Articles
other:Article Title: Systematic Multi-Target QSAR Benchmarking: Machine Learning Algorithms, Molecular Descriptors, and Validation. Article Snippet: Quantitative structure−activity relationship (QSAR) modeling underpins computational drug discovery, yet the factors governing model generalizability across structurally novel compounds, and across protein families, remain incompletely understood.. This study addresses that gap through systematic 2D-QSAR benchmarking across four therapeutically diverse ChEMBL targets, EGFR (kinase, n = 10, 036), DRD2 (GPCR, n = 7, 558), BACE-1 (protease, n = 8, 080), and hERG (ion channel, n = 8, 077), totaling 33,751 compounds under identical experimental conditions.. Three principal findings emerge. |